The global myomectomy market size is anticipated to reach USD 1.1 billion by 2027, expanding at a CAGR of 9.1%, according to a new report by Grand View Research, Inc. An increasing number of patients suffering from health issues such as uterine fibroids, endometriosis, and chronic pelvic pain are factors driving the market.
Myomectomy is the surgical method to eradicate fibroids without affecting the healthy tissue of the uterus. Fibroids majorly develop in 50.0% of women, which have led to increased demand for the procedure and it preserves the uterus, unlike hysterectomy. Therefore, it is considered the standard of care for eliminating fibroids. This is anticipated to boost market growth over the forecast period.
Request a sample Copy of the Global Myomectomy Market Research Report @ https://www.grandviewresearch.com/industry-analysis/myomectomy-market/request/rs1
Moreover, increased patient preference for less invasive treatments is expected to boost the market growth. Nowadays, minimally invasive treatment options for the procedure include laparoscopic or robotic, and hysteroscopic myomectomy. All these techniques are minimally invasive and eliminate the need for general anesthesia. These procedures also cause less discomfort and post-operative pain.
Furthermore, the incorporation of new technologies and the introduction of new products by market players are expected to boost market growth during the forecast period. For instance, Intuitive Surgical has launched the Single Port Platform”-da Vinci SP Surgical System. It enables doctors with robotic-assisted technology intended for deep and narrow access to tissue during various urological procedures.
Key suggestions from the report:
- Based on type, the abdominal myomectomy segment dominated the market with a share of 39.4% in 2019, as this procedure is the established permanent solution for large fibroids growing in the uterine wall
- On the basis of product, others segment dominated the overall market with a share of 36.64% in 2019. Since, this segment offers benefits such as same-day procedure, less invasive treatment, and faster recovery as compared to other products
- North America dominated the market with a major share of 53.05% in 2019 owing to the increasing uterus related illnesses in the region and availability of the latest treatment procedures.
Have Any Query? Ask Our Experts @ https://www.grandviewresearch.com/inquiry/450838/ibb
Grand View Research has segmented the global myomectomy market on the basis of type, product, and region:
Myomectomy Type Outlook (Revenue, USD Million, 2016 – 2027)
- Abdominal Myomectomy
- Hysteroscopic Myomectomy
- Laparoscopic Myomectomy
Myomectomy Product Outlook (Revenue, USD Million, 2016 – 2027)
- Laparoscopic Power Morcellators
- Harmonic Scalpel
- Laparoscopic Sealer
- Others
Myomectomy Regional Outlook (Revenue, USD Million, 2016 – 2027)
- North America
- The U.S.
- Canada
- Europe
- The U.K.
- Germany
- France
- Italy
- Spain
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Latin America
- Mexico
- Brazil
- Argentina
- Colombia
- The Middle East & Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
List of Key Players of Myomectomy Market
- Medtronic
- Stryker Corporation
- CONMED Corporation
- INSIGHTEC
- CooperSurgical Inc.
- Hologic, Inc.
- Intuitive Surgical
- Karl Storz
- B. Braun Melsungen AG
Find more research reports on Medical Devices Industry, by Grand View Research:
Smoke Evacuation Systems Market – The global smoke evacuation systems market size was valued at USD 145.4 million in 2018 and is expected to register a CAGR of 6.6% during the forecast period.
Laparoscopic Devices Market – The global laparoscopic devices market size was valued at USD 5.94 billion in 2018 and is anticipated to expand at a CAGR of 6.6% over the forecast period.
About Grand View Research
Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.
Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:201, Spear Street, 1100
City: San Francisco
State: California
Country: United States
Website: https://www.grandviewresearch.com/industry-analysis/myomectomy-market